Nkarta, Inc.
Nkarta, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 25 | 27 | 40 | 60 | 53 | 53 | 28 | 57 | 120 | 250 | 31 | 38 | |||||
Short Term Investments | 158 | 203 | 237 | 222 | 236 | 213 | 239 | 226 | 204 | 187 | 217 | 237 | |||||
Prepaid Expense And Other Assets Current | 5 | 5 | 6 | 7 | 7 | 6 | 6 | 7 | 7 | 5 | 5 | 6 | |||||
Assets Current | 188 | 236 | 283 | 289 | 297 | 272 | 273 | 290 | 332 | 443 | 253 | 281 | |||||
Long Term Investments | 58 | 34 | 16 | 31 | 42 | 84 | 110 | 119 | 99 | 10 | - | - | |||||
Restricted Cash Noncurrent | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Property Plant And Equipment Net | 57 | 64 | 67 | 68 | 70 | 73 | 75 | 76 | 78 | 79 | 79 | 78 | |||||
Operating Lease Right Of Use Asset | 31 | 34 | 34 | 34 | 35 | 36 | 36 | 39 | 39 | 39 | 40 | 41 | |||||
Other Assets Noncurrent | 1 | 2 | 2 | 2 | 2 | 5 | 4 | 5 | 4 | 4 | 4 | 4 | |||||
Assets | 338 | 372 | 404 | 427 | 448 | 471 | 501 | 532 | 554 | 577 | 379 | 406 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 4 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | 4 | 3 | 4 | 4 | |||||
Operating Lease Liability Current | 7 | 7 | 7 | 6 | 7 | 6 | 6 | 7 | 6 | 6 | 6 | 6 | |||||
Accrued Liabilities Current | 12 | 10 | 13 | 11 | 11 | 11 | 12 | 14 | 12 | 13 | 14 | 15 | |||||
Liabilities Current | 24 | 18 | 22 | 19 | 19 | 19 | 19 | 22 | 21 | 22 | 23 | 26 | |||||
Operating Lease Liability Noncurrent | 66 | 68 | 70 | 70 | 72 | 73 | 74 | 79 | 80 | 81 | 82 | 83 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Liabilities | 90 | 86 | 92 | 89 | 91 | 92 | 93 | 101 | 101 | 103 | 106 | 109 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 965 | 962 | 960 | 958 | 956 | 954 | 952 | 947 | 943 | 939 | 709 | 705 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | -0 | 0 | 1 | 0 | 1 | 1 | 2 | -0 | -0 | 0 | -0 | |||||
Retained Earnings Accumulated Deficit | -717 | -676 | -648 | -621 | -599 | -576 | -544 | -518 | -490 | -465 | -435 | -408 | |||||
Stockholders Equity | 248 | 286 | 312 | 338 | 358 | 379 | 408 | 431 | 453 | 474 | 273 | 297 | |||||
Liabilities And Stockholders Equity | 338 | 372 | 404 | 427 | 448 | 471 | 501 | 532 | 554 | 577 | 379 | 406 | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | |||||
Preferred Stock Shares Authorized | - | - | 54 | - | - | - | 54 | - | - | - | 54 | - | |||||
Preferred Stock Shares Issued | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | |||||
Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | |||||
Common Stock Par Or Stated Value Per Share | - | - | 0 | - | - | - | 0 | - | 0 | - | 0 | - | |||||
Common Stock Shares Authorized | - | - | 200 | - | - | - | 200 | - | 100 | - | 100 | - | |||||
Common Stock Shares Issued | - | - | 71 | - | - | - | 71 | - | - | - | 49 | - | |||||
Shares Outstanding | - | - | 71 | - | - | - | 71 | - | - | - | 49 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -23.48% | -1.83% | -36.28% | - | - | - | - | - | - | - | - | - |
| 2025 | 1.60% | -6.42% | 13.37% | 15.31% | 8.67% | 7.65% | -8.16% | -4.59% | 13.27% | 62.91% | 23.94% | 34.27% |
| 2024 | 7.78% | -6.19% | 11.75% | 7.04% | -21.13% | -35.81% | -12.23% | -26.30% | -23.85% | 32.12% | 27.01% | 35.77% |
| 2023 | - | - | - | - | - | - | 32.68% | 221.95% | 347.32% | -32.67% | -51.85% | -49.15% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 7.98 | 12.96 | 12.69 | 15.23 | 15.67 | 14.48 | 14.45 | 12.91 | 15.91 | 19.95 | 10.85 | 10.97 | |||||
| Quick Ratio | 7.76 | 12.66 | 12.41 | 14.87 | 15.31 | 14.16 | 14.13 | 12.60 | 15.57 | 19.71 | 10.64 | 10.75 | |||||
| Working Capital | 164.48M | 217.68M | 260.25M | 270.29M | 277.64M | 252.80M | 254.42M | 267.68M | 310.94M | 420.59M | 229.74M | 255.55M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.36 | 0.30 | 0.29 | 0.26 | 0.25 | 0.24 | 0.23 | 0.23 | 0.22 | 0.22 | 0.39 | 0.37 | |||||
| Debt Ratio | 0.27 | 0.23 | 0.23 | 0.21 | 0.20 | 0.20 | 0.19 | 0.19 | 0.18 | 0.18 | 0.28 | 0.27 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -1.57 | -1.35 | -1.41 | -1.39 | -1.48 | -1.51 | -1.60 | -1.50 | -1.47 | -2.29 | -2.40 | -2.49 | |||||
| Free Cash Flow Per Share TTM | -1.29 | -1.20 | -1.23 | -0.87 | -0.96 | -1.43 | -1.53 | -1.47 | -1.49 | -2.32 | -2.33 | -2.58 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | 7.40% | -10.18% | -4.33% | -7.23% | 1.23% | -4.26% | -7.41% | -9.58% | -13.69% | -2.07% | 3.22% | 17.55% | |||||
| EPS Growth (1Y) | 6.66% | -10.59% | -12.25% | -7.81% | 0.57% | -34.35% | -33.13% | -39.70% | -42.49% | -5.48% | -8.12% | 16.51% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1.80 | -1.57 | -1.32 | -1.49 | -1.12 | -1.22 | -1.55 | -3.01 | -4.03 | -4.71 | -2.75 | -0.56 | |||||
| P/B TTM | 0.85 | 0.55 | 0.44 | 0.45 | 0.34 | 0.36 | 0.41 | 0.77 | 0.96 | 1.16 | 1.18 | 0.23 | |||||
| Market Cap | 210.82M | 156.68M | 136.88M | 153.23M | 122.80M | 136.01M | 168.98M | 332.51M | 434.35M | 547.88M | 323.49M | 68.20M | |||||
| Enterprise Value | 183.12M | 126.59M | 94.51M | 93.12M | 69.39M | 80.67M | 138.37M | 272.80M | 311.21M | 297.59M | 292.45M | 27.19M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -95.90M | -89.17M | -90.68M | -64.20M | -70.83M | -105.55M | -104.11M | -108.41M | -109.55M | -117.41M | -114.31M | -126.52M | |||||
| Net Debt | -27.70M | -30.10M | -42.38M | -60.11M | -53.41M | -55.34M | -30.62M | -59.70M | -123.14M | -250.29M | -31.04M | -41.01M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Nkarta, Inc. (NKTX) — SEC Financial Statements & Analysis
Nkarta, Inc. (NKTX) is a pharmaceutical preparations company, incorporated in DE. Nkarta, Inc. trades on Nasdaq as: NKTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Nkarta, Inc. reported a Debt-to-Equity ratio of 0.36x, a Price-to-Book (P/B) ratio of 0.85x (TTM), at a market cap of $210.82M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.36x
- P/B TTM
- 0.85x
- Market Cap
- $210.82M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Nkarta, Inc. in?
Nkarta, Inc. (NKTX) operates in the Pharmaceutical Preparations industry.
What is NKTX's market cap?
Nkarta, Inc. (NKTX) has a market capitalization of $210.82M as of 2026-06-30.
What exchange does NKTX trade on?
Nkarta, Inc. (NKTX) trades on the Nasdaq.
Where is Nkarta, Inc. incorporated?
Nkarta, Inc. is incorporated in DE.